US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist
  • 10.410
  • +1.420+15.80%
Close Feb 14 16:00 ET
  • 10.410
  • 0.0000.00%
Post 20:01 ET
347.88MMarket Cap-6.30P/E (TTM)

About MBX Biosciences Company

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

Company Profile

SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200
Websitehttp://www.mbxbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Peter Kent Hawryluk
  • President, Chief Executive Officer and Director
  • 4.86M
  • Dr. Salomon Azoulay, M.D.
  • Chief Medical Officer
  • --
  • Richard B. Bartram
  • Chief Financial Officer and Principal Accounting Officer
  • 1.05M
  • Patrick J. Heron
  • Independent Director
  • --
  • Dr. Tiba Aynechi, PhD
  • Independent Director
  • --
  • Dr. Steven Ryder, M.D.
  • Independent Director
  • --
  • James M. Cornelius
  • Independent Director
  • --
  • Edward T. Mathers
  • Independent Director
  • --
  • Dr. Ora H. Pescovitz, M.D.
  • Independent Director
  • --
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!